Oruka Therapeutics, Inc. short interest in 2026
In 2026, Oruka Therapeutics, Inc.'s disclosed short interest ran from 10.83% of shares outstanding on 15 Jan 2026 to 11.51% on 15 Sep 2026, a change of +0.68 percentage points. The year's high was 15.19% on 30 Jun 2026 and its low 7.53% on 13 Mar 2026, averaging 11.10% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.60 days on 27 Feb 2026. Full history: Oruka Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 10.83% (15 Jan 2026)
- End of year
- 11.51% (15 Sep 2026)
- Change
- +0.68 pp
- High
- 15.19% (30 Jun 2026)
- Low
- 7.53% (13 Mar 2026)
- Average
- 11.10%
- Highest days to cover
- 15.60 (27 Feb 2026)
- SEC filings marked
- 5
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 10.83% | 11.02 | |
| 30 Jan 2026 | 10.14% | 8.88 | |
| 13 Feb 2026 | 8.39% | 11.49 | |
| 27 Feb 2026 | 9.23% | 15.60 | |
| 13 Mar 2026 | 7.53% | 7.48 | 10-K filed |
| 31 Mar 2026 | 9.34% | 5.02 | |
| 15 Apr 2026 | 11.44% | 4.04 | |
| 30 Apr 2026 | 11.59% | 2.62 | results (8-K) |
| 15 May 2026 | 10.37% | 3.57 | 10-Q filed |
| 29 May 2026 | 10.57% | 4.97 | |
| 15 Jun 2026 | 11.44% | 6.08 | |
| 30 Jun 2026 | 15.19% | 4.29 | |
| 15 Jul 2026 | 14.65% | 6.24 | |
| 31 Jul 2026 | 12.16% | 8.38 | |
| 14 Aug 2026 | 12.54% | 11.33 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 11.77% | 9.27 | |
| 15 Sep 2026 | 11.51% | 11.61 |
See also: Oruka Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.